Spherusol 12.7 ug/mL
Coccidioides immitis Spherule-Derived Skin Test Antigen · INJECTION, SOLUTION · Nielsen BioSciences, Inc.
Spherusol is a injection, solution containing coccidioides immitis spherule-derived skin test antigen at 12.7 ug/mL, taken intradermal. Manufactured by Nielsen BioSciences, Inc..
Key Facts
- Brand Name
- Spherusol
- Generic Name
- Coccidioides immitis Spherule-Derived Skin Test Antigen
- NDC Code (Product)
59584-140- Manufacturer
- Nielsen BioSciences, Inc.
- Strength
- 12.7 ug/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRADERMAL
- Marketing Status
- Application #
- BLA125354
- Drug Class
- Skin Test Antigen [EPC]
- Marketing Start
- 07/29/2011
Recall History
No Recall HistoryFrequently Asked Questions
What is Spherusol used for?
Spherusol contains Coccidioides immitis Spherule-Derived Skin Test Antigen. It is a injection, solution taken intradermal. Consult your doctor for specific uses.
Is Spherusol a controlled substance?
Spherusol is not classified as a controlled substance by the DEA.
What is the generic name for Spherusol?
The generic name for Spherusol is Coccidioides immitis Spherule-Derived Skin Test Antigen. There are no other listed brand versions of Coccidioides immitis Spherule-Derived Skin Test Antigen.
What is the NDC code for Spherusol 12.7 ug/mL?
The NDC (National Drug Code) for Spherusol 12.7 ug/mL is 59584-140, listed by Nielsen BioSciences, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)